case_images: PMC11398957_01
case_images: Clinical manifestation of the patient. (a) Facial erythema, edema, and (b) scaly erythematous macules and papules on the trunk and extremities. The total lesions cover over 80% of the body surface area.
case_images: CRIDM2024-1018971.001.jpg
case_images: PMC11398957_01_CRIDM2024-1018971.001.jpg
case_images: fig1
case_images: Physical examination revealed facial erythematous edema, scaly erythematous macules, and papules on the trunk and extremities, covering over 80% of the body surface area (Figures 1(a) and 1(b)).
case_images: Dermatopathological manifestation of the patient revealed dyskeratosis, interface dermatitis, melanin, and eosinophils in the superficial dermis (H&E x400).
case_images: CRIDM2024-1018971.002.jpg
case_images: PMC11398957_01_CRIDM2024-1018971.002.jpg
case_images: fig2
case_images: Dermatopathology examination revealed dyskeratosis, interface dermatitis, melanin pigment incontinence, and eosinophils in the superficial dermis, indicating drug-induced manifestation (Figure 2).